However, this study found that some patients with IBC, but not in DCIS, had very high levels of HER2 auto-antibodies, suggesting that B cells in these women are reactivated by breast cancer cells that antigen presenting T cells are able to access easily (Tabuchi et al., 2016). This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.